Cagrilintide / Semaglutide BlendThis research peptide blend combines Cagrilintide, an amylin receptor agonist analogue, with Semaglutide, a GLP-1 receptor agonist peptide. The blend is used in laboratory studies to explore multi-receptor peptide interactions, metabolic signalling pathways, and pharmacokinetic profiles of combined peptide administration. Researchers utilise this formulation to investigate potential synergistic effects in controlled experimental models.Disclaimer: For laboratory research purposes only. Not for human or animal use.
Super Sale Extra 20% OFF! Use Code:ROCK20 
